American Well Corporation
New York Stock ExchangeRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- American Well Corporation American Well Corporation (AMWL), doing business as Amwell and founded in 2006 with headquarters in Boston, Massachusetts, operates as a leading enterprise telehealth platform provider that digitally enables hybrid care delivery, including in-person, virtual, and automated services, primarily to health systems, health plans, employers, providers, government entities, and innovators across the United States and internationally. The company offers its flagship Converge cloud-based platform, which supports virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health; specialty care programs encompassing dermatology, musculoskeletal care, second opinion, and cardiometabolic care; Carepoint devices that convert carts, peripherals, tablets, and TVs into digital access points in clinical settings; Amwell Medical Group network services featuring primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services; and professional services for implementation, workflow design, systems integration, service expansion, patient engagement, and provider engagement. Amwell sells its solutions through field sales professionals, channel partners, and value-added resellers, targeting providers, payers, government, and higher education sectors while enabling care across the healthcare continuum from urgent care to high-acuity specialty consults like telestroke and telepsychiatry. In recent developments, the company outlines a 2025 revenue target of $245 million to $248 million with a strategic shift toward high-margin AI initiatives and operational efficiency aimed at achieving cash flow break-even by the end of 2026; reports third-quarter 2025 revenue of $56.3 million despite an 8% year-over-year decline, alongside improved adjusted EBITDA losses and key platform deployments such as replacing MHS Video Connect with full integration into MHS GENESIS electronic health records, nearly tripling virtual visits, and expanding to the U.S. Coast Guard and Military Entrance Processing Command; and won a significant contract with Florida Blue while exploring potential divestitures of non-core assets to streamline operations and enhance its core AI and innovation focus.
Company News
Amwell® receives Frost & Sullivan's 2026 Technology Innovation Leadership Recognition for addressing healthcare fragmentation
Amwell® to participate in upcoming investor conferences
American Well (AMWL) Upgraded to Buy: What Does It Mean for the Stock?
Here Is Why Bargain Hunters Would Love Fast-paced Mover American Well (AMWL)
Amwell makes grant to new employees under inducement plan
American Well Corporation (AMWL) Q2 2026 Earnings Call Transcript
American Well Q2 Earnings Call Highlights
American Well Corporation (AMWL) Reports Q2 Loss, Beats Revenue Estimates
Amwell® Announces Results for the Second Quarter 2026
Amwell® to report second quarter 2026 operating results
American Well (AMWL) Soars 11.1%: Is Further Upside Left in the Stock?
American Well (AMWL) Moves 9.4% Higher: Will This Strength Last?
American Well (AMWL) Upgraded to Buy: Here's Why
Fast-paced Momentum Stock American Well (AMWL) Is Still Trading at a Bargain
Is American Well (AMWL) Stock Outpacing Its Medical Peers This Year?
Why Fast-paced Mover American Well (AMWL) Is a Great Choice for Value Investors
Amazon's top health exec is stepping down, will be replaced by Amwell co-founder
Amazon puts Amwell co-founder in charge of healthcare unit; longtime executive to depart
Nature Human Behaviour study finds SilverCloud® by Amwell® reduced prevalence of mental disorders over two years at scale
Amwell® to Participate in Upcoming Investor Conference